• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症:内皮功能障碍的关键模型。

Systemic Sclerosis: A Key Model of Endothelial Dysfunction.

作者信息

Zaccone Vincenzo, Falsetti Lorenzo, Contegiacomo Silvia, Cataldi Serena, Benfaremo Devis, Moroncini Gianluca

机构信息

PhD Course in Human Health, Marche Polytechnic University, 60126 Ancona, Italy.

Clinica Medica, Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.

出版信息

Biomedicines. 2025 Jul 19;13(7):1771. doi: 10.3390/biomedicines13071771.

DOI:10.3390/biomedicines13071771
PMID:40722841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12292601/
Abstract

Systemic sclerosis (SSc) is a heterogeneous disease characterized by vascular alterations, immune dysregulation, and fibrosis. Solid evidence supports the hypothesis that endothelial dysfunction is the key player in SSc vascular injury and a critical factor concurring to the initiation of SSc pathogenesis. This narrative review reports on persistent endothelial dysfunction, resulting from oxidative stress, autoimmunity, and impaired vascular repair, in the course of SSc, and how it can trigger and sustain fibrotic remodeling of various organs. In this paper, we also analyze the impact on SSc of impaired angiogenesis and vasculogenesis, diminished endothelial progenitor cell function, and endothelial-to-mesenchymal transition, which can collectively disrupt vascular homeostasis and promote myofibroblast activation. These pathologic events underlie the hallmark clinical manifestations, i.e., Raynaud's phenomenon, digital ulcers, pulmonary arterial hypertension, and scleroderma renal crisis. The review highlights how recognizing SSc as a paradigm of systemic endothelial dysfunction may reframe our understanding of its physiopathology, modify current therapeutic strategies, and unveil new therapeutic targets.

摘要

系统性硬化症(SSc)是一种异质性疾病,其特征为血管改变、免疫失调和纤维化。确凿证据支持以下假说:内皮功能障碍是SSc血管损伤的关键因素,也是促成SSc发病机制起始的关键因素。本叙述性综述报道了在SSc病程中,由氧化应激、自身免疫和血管修复受损导致的持续性内皮功能障碍,以及它如何引发和维持各器官的纤维化重塑。在本文中,我们还分析了血管生成和血管发生受损、内皮祖细胞功能减退以及内皮向间充质转化对SSc的影响,这些因素共同作用可破坏血管稳态并促进肌成纤维细胞活化。这些病理事件是标志性临床表现的基础,即雷诺现象、指端溃疡、肺动脉高压和硬皮病肾危象。该综述强调,将SSc视为系统性内皮功能障碍的范例,可能会重塑我们对其生理病理学的理解,修改当前的治疗策略,并揭示新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c3/12292601/5cf0fb2271dd/biomedicines-13-01771-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c3/12292601/5cf0fb2271dd/biomedicines-13-01771-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c3/12292601/5cf0fb2271dd/biomedicines-13-01771-g001.jpg

相似文献

1
Systemic Sclerosis: A Key Model of Endothelial Dysfunction.系统性硬化症:内皮功能障碍的关键模型。
Biomedicines. 2025 Jul 19;13(7):1771. doi: 10.3390/biomedicines13071771.
2
The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.系统性硬皮病血管病变中内皮细胞的作用:系统评价。
Autoimmun Rev. 2017 Aug;16(8):774-786. doi: 10.1016/j.autrev.2017.05.024. Epub 2017 May 29.
3
A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients.基于 PRISMA 的系统性硬化症患者发生手指溃疡预测性风险因素的系统评价。
Autoimmun Rev. 2015 Feb;14(2):140-52. doi: 10.1016/j.autrev.2014.10.009. Epub 2014 Oct 14.
4
Calcium channel blockers for primary and secondary Raynaud's phenomenon.用于原发性和继发性雷诺现象的钙通道阻滞剂。
Cochrane Database Syst Rev. 2017 Dec 13;12(12):CD000467. doi: 10.1002/14651858.CD000467.pub2.
5
Stem cell transplantation for systemic sclerosis.系统性硬皮病的干细胞移植。
Cochrane Database Syst Rev. 2022 Jul 29;7(7):CD011819. doi: 10.1002/14651858.CD011819.pub2.
6
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review.巨噬细胞在系统性硬化症进行性纤维化中的干预作用:系统评价。
Autoimmun Rev. 2024 Oct;23(10):103637. doi: 10.1016/j.autrev.2024.103637. Epub 2024 Sep 8.
7
Light at the ENDothelium-role of Sox17 and Runx1 in endothelial dysfunction and pulmonary arterial hypertension.内皮细胞中的光——Sox17和Runx1在内皮功能障碍和肺动脉高压中的作用
Front Cardiovasc Med. 2023 Nov 2;10:1274033. doi: 10.3389/fcvm.2023.1274033. eCollection 2023.
8
Dynamics of interstitial lung disease following immunosuppressive treatment differ between antisynthetase syndrome and systemic sclerosis.免疫抑制治疗后间质性肺疾病的动态变化在抗合成酶综合征和系统性硬化症之间存在差异。
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251336896. doi: 10.1177/17534666251336896. Epub 2025 May 8.
9
Unfolding the pathogenesis of scleroderma through genomics and epigenomics.通过基因组学和表观基因组学揭示硬皮病的发病机制。
J Autoimmun. 2017 Sep;83:73-94. doi: 10.1016/j.jaut.2017.05.004. Epub 2017 May 16.
10
Increased oxidative stress response in circulating blood of systemic sclerosis patients - relation to disease characteristics and inflammatory blood biomarkers.系统性硬化症患者循环血液中氧化应激反应的增加 - 与疾病特征和炎症血液生物标志物的关系。
Semin Arthritis Rheum. 2023 Oct;62:152228. doi: 10.1016/j.semarthrit.2023.152228. Epub 2023 Jun 9.

本文引用的文献

1
Insights Into the Cellular and Molecular Mechanisms Behind the Antifibrotic Effects of Nerandomilast.奈拉米司特抗纤维化作用背后的细胞和分子机制洞察
Am J Respir Cell Mol Biol. 2025 Apr 16. doi: 10.1165/rcmb.2024-0614OC.
2
Immunoglobulins G from Patients with Systemic Sclerosis Modify the Molecular Signatures of Endothelial Cells.系统性硬化症患者的免疫球蛋白G改变内皮细胞的分子特征。
RMD Open. 2025 Mar 23;11(1):e004290. doi: 10.1136/rmdopen-2024-004290.
3
Interleukin-17A is a potential therapeutic target predicted by proteomics for systemic sclerosis patients at high risk of pulmonary arterial hypertension.
白细胞介素-17A 是一种通过蛋白质组学预测的系统性硬化症患者发生肺动脉高压高危人群的潜在治疗靶点。
Sci Rep. 2024 Nov 27;14(1):29484. doi: 10.1038/s41598-024-76987-6.
4
Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-β1 Pathway.奈拉米司特通过调节转化生长因子-β1通路改善博来霉素诱导的小鼠系统性硬化症相关间质性肺病。
Inflammation. 2024 Oct 23. doi: 10.1007/s10753-024-02153-9.
5
Transcriptomic characterization of lung pericytes in systemic sclerosis-associated pulmonary fibrosis.系统性硬化症相关肺纤维化中肺周细胞的转录组学特征
iScience. 2024 May 17;27(6):110010. doi: 10.1016/j.isci.2024.110010. eCollection 2024 Jun 21.
6
Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosis.单细胞转录组和内皮细胞染色质可及性揭示了与系统性硬化症中血管生成失调相关的转录因子。
Ann Rheum Dis. 2024 Sep 30;83(10):1335-1344. doi: 10.1136/ard-2023-225415.
7
Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics.基于空间蛋白质组学的系统性硬化症血管龛特征描述。
Circ Res. 2024 Mar 29;134(7):875-891. doi: 10.1161/CIRCRESAHA.123.323299. Epub 2024 Mar 5.
8
Endothelial Dysfunction in Systemic Sclerosis.系统性硬化症中的血管内皮功能障碍。
Int J Mol Sci. 2023 Sep 21;24(18):14385. doi: 10.3390/ijms241814385.
9
The Yin and Yang of IL-17 in Systemic Sclerosis.系统性硬化症中白细胞介素-17 的阴阳两面。
Front Immunol. 2022 May 4;13:885609. doi: 10.3389/fimmu.2022.885609. eCollection 2022.
10
Pulmonary arterial hypertension in systemic sclerosis: Diagnosis and treatment according to the European Society of Cardiology and European Respiratory Society 2015 guidelines.系统性硬化症中的肺动脉高压:根据欧洲心脏病学会和欧洲呼吸学会2015年指南进行诊断和治疗
J Scleroderma Relat Disord. 2019 Feb;4(1):35-42. doi: 10.1177/2397198318808998. Epub 2018 Nov 14.